Wright Medical Group, Inc. (NASDAQ: WMGI) today announced that it will host a conference call on Tuesday, May 1, 2012 at 3:30 p.m. Central Time to discuss the Company’s operating results for its first quarter ended March 31, 2012. Operating results will be released at 3:00 p.m. Central Time that day.
The live dial-in number for the call is 800-659-2032 (U.S.) / 617-614-2712 (International). The participant passcode for the call is “Wright.” A simultaneous webcast of the call will be available via Wright Medical’s corporate website at
. The call will also be archived on this site for a minimum of 12 months.
A recording of the call will be available beginning at 5:30 p.m. Central Time on May 1, 2012 through May 8, 2012. To hear this recording, dial 888-286-8010 (U.S.) / 617-801-6888 (International) and enter code 47749217.
About Wright Medical
Wright Medical Group, Inc. is a global orthopaedic medical device company and a leading provider of surgical solutions for the foot and ankle market. The Company specializes in the design, manufacture and marketing of devices and biologic products for extremity, hip and knee repair and reconstruction. The Company has been in business for 60 years and markets its products in over 60 countries worldwide. For more information about Wright Medical, visit the Company’s website at
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
The conference call and webcast may contain “forward-looking statements” as defined under U.S. federal securities laws.
These statements reflect management’s current knowledge, assumptions, beliefs, estimates, and expectations and express management’s current views of future performance, results, and trends and may be identified by their use of terms such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “predict,” “project,” “will,” and other similar terms.
Forward-looking statements are subject to a number of risks and uncertainties that could cause our actual results to materially differ from those described in the forward-looking statements.
Such risks and uncertainties include the impact of Wright's settlement of the federal investigation into Wright's consulting arrangements with orthopaedic surgeons relating to its hip and knee products in the United States, including Wright's compliance with a Deferred Prosecution Agreement through September 2012 and a Corporate Integrity Agreement through September 2015, and those risks and uncertainties discussed in our filings with the Securities and Exchange Commission (including those described in Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2011, under the heading, “Risk Factors”), including demand for and market acceptance of our new and existing products; future actions of governmental authorities and other third parties; tax measures; business development and growth opportunities; product quality or patient safety issues; products liability claims; enforcement of our intellectual property rights; the geographic and product mix impact on our sales; retention of sales representatives and independent distributors; inventory reductions or fluctuations in buying patterns by wholesalers or distributors; ability to realize the anticipated benefits of restructuring initiatives; and impact of the commercial and credit environment on us and our customers and suppliers.
Readers should not place undue reliance on forward-looking statements.